36 results
8-K
EX-99.1
SIENQ
Sientra Inc
12 Mar 19
Sientra Reports Fourth Quarter and Full Year 2018 Financial Results
4:31pm
of which demonstrate our commitment to patient safety and continued innovation for the benefit of our plastic surgeon partners and their patients … is grounded in the strong confidence we have in our 10-year clinical data. We also opened our state-of-the-art Sientra Lab and Innovation Center
8-K
EX-99.1
SIENQ
Sientra Inc
12 May 22
Sientra Reports Seventh Consecutive Quarter of Record Growth for First Quarter 2022
4:09pm
and augmentation segments, adding over 200 new accounts.
Hosted first ever R&D Day highlighting Sientra’s strategic vision and innovation pipeline … in reconstruction and the way we started 2022 positions Sientra closer to that goal. We believe our history of best-in-class innovation, safety and clinically
8-K
EX-99.1
SIENQ
Sientra Inc
11 Mar 20
Sientra Reports Fourth Quarter and Full Year 2019 Financial Results
4:26pm
integration through our fourth-quarter acquisition of OPUS® breast implant manufacturing operations from Vesta, which complements our innovation lab, enables … confident our recent achievements, well-capitalized balance sheet, talented team and commitment to innovation will drive significant value for our
8-K
SIENQ
Sientra Inc
22 Jul 21
Departure of Directors or Certain Officers
5:22pm
of Innovation at MGB/Partners HealthCare from 2000 to 2013. Dr. Erenburg is also a co-founder and board member of R2 Technologies, Inc., AVAVA, Inc
8-K
EX-99.1
SIENQ
Sientra Inc
7 Aug 18
Sientra Reports Second Quarter 2018 Financial Results
12:00am
solutions within both product segments. The launch of SLICE, the Sientra Laboratory and Innovation Center of Excellence, will drive product development
424B5
n2qllxqmigsc
3 Jun 19
Prospectus supplement for primary offering
4:01pm
424B5
6ut6f0z
5 Jun 19
Prospectus supplement for primary offering
4:03pm
DRS
tna wlnqh0
18 Jul 14
Draft registration statement
12:00am
10-K
967o51l4a6lbdwn8h56
18 Mar 15
Annual report
12:00am
S-1
ogolvnw8d88it1
19 Sep 14
IPO registration
12:00am
DRS/A
fnm2282jnrpd3x8x
27 Aug 14
Draft registration statement (amended)
12:00am
S-1/A
5afct
10 Oct 14
IPO registration (amended)
12:00am
424B1
mvgqjv1
29 Oct 14
Prospectus with pricing info
12:00am